Growth Factor Roles in Soft Tissue Physiology and Pathophysiology

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Tendon repair historically presents challenges with unsatisfactory outcomes.
• Growth factor research offers novel therapeutic avenues for tendon and arterial disorders.
• Heritable disorders affecting soft tissues like aorta, valves, and tendons involve transforming growth factor β (TGFß).

Purpose of the Study:

• To explore the potential of various growth factors in enhancing tendon healing and repair.
• To investigate the role of specific growth factors like TGFß, bone morphogenetic proteins, FGFs, IGF-I, and VEGF in soft tissue regeneration.
• To evaluate emerging therapeutic modalities such as platelet-rich plasma (PRP) and mesenchymal stem cells for tendon injuries.

Main Methods:

• Review of current research on growth factors and their biological effects on tendon and soft tissue healing.
• Analysis of the roles of specific growth factors (TGFß, BMPs, FGFs, IGF-I, VEGF) in pathogenesis and repair.
• Examination of experimental and clinical data on the application of PRP and mesenchymal stem cells in tendon healing.

Main Results:

• Transforming growth factor β (TGFß) is implicated in heritable soft tissue disorders.
• Bone morphogenetic proteins are being tested for bone and tendon fracture healing.
• Fibroblast growth factors (FGFs) are crucial for embryonic tendon development, with potential for new treatments if angiogenicity is controlled.
• Insulin-like growth factor I (IGF-I) role in tendon repair requires clarification regarding growth hormone dependency.
• Platelet-derived growth factor (PDGF) and FGF2, alone or with IGF-I, stimulate periodontal ligament regeneration.
• Vascular endothelial growth factor (VEGF) may negatively impact tendon healing due to angiogenic activity and matrix metalloproteinase stimulation.
• Platelet-rich plasma (PRP) and mesenchymal stem cells show success in equine tendon healing but require more research for human application.

Conclusions:

• Growth factors like TGFß, BMPs, and FGFs present significant potential for advancing tendon repair strategies.
• Further research is essential to elucidate the precise mechanisms and optimize the application of growth factors and cell-based therapies (PRP, MSCs) for human tendon injuries.
• Controlling the angiogenic effects of growth factors is critical for developing safe and effective treatments.